ArticleNature microbiology2021
Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
Open access · bronzeAbstract read
In one paragraph
Article in Nature microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 65 citations in OpenAlex.
- Tropism ofEmerging microbes & infections · 2026Article
- Host Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum.The Journal of infectious diseases · 2026Article
- The SLC-ome of membrane transport: from molecular discovery to physiology and clinical applications.Physiological reviews · 2026Review
- Nanobodies against Plasmodium adhesins that block receptor engagement and malaria parasite invasion.The Biochemical journal · 2026Article
- SLC3A2 promotes early-stage of Zika virus infection in human placental cells and astrocytes.Infectious diseases & immunity · 2026Article
- Highly conserved Plasmodium vivax genomes in Duffy-negative individuals from Sudan.Scientific reports · 2025Article
- Article
- Intestinal Goblet Cell-Expressed Reg4 Ameliorates Intestinal Inflammation Potentially by Restraining Pathogenic Escherichia coli Infection.Probiotics and antimicrobial proteins · 2025Article
- The pattern of gene amplification of members of the Plasmodium vivax erythrocyte binding-like proteins family across the Amazon rainforest.Malaria journal · 2025Article
- Targeting anemia-induced CD71Infection and immunity · 2025Article
- Genomic analysis of Plasmodium vivax field isolates circulating in sub-Saharan Africa.Communications biology · 2025Article
- Article
- A novel micronemal protein MP38 is involved in the invasion of merozoites into erythrocytes.mBio · 2025Article
- Severe malaria enforces short-lived effector cell differentiation but does not prevent effective secondary responses by memory CD8 T cells.PLoS pathogens · 2025Article
- The reticulocyte restriction: invasion ligand RBP1a ofFrontiers in cellular and infection microbiology · 2025Article
- Malian field isolates provide insight into Plasmodium malariae intra-erythrocytic development and invasion.PLoS neglected tropical diseases · 2025Article
- Blood group antigens and malaria susceptibility.Frontiers in cellular and infection microbiology · 2025Review
- Majority of the erythrocyte binding proteins of the Pvfam "a" family ofFrontiers in cellular and infection microbiology · 2025Article
- The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from Cambodia.NPJ vaccines · 2024Article
- Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2a.The Journal of infectious diseases · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 10 institutions in 6 countries.
Benoît MalleretSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore. Benoit_Malleret@nus.edu.sg.ORCID http://orcid.org/0000-0001-9658-7528
Abbas El Sahili *School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Matthew Zirui Tay *Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
Guillaume Carissimo *Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.ORCID http://orcid.org/0000-0002-9703-9096
Alice Soh Meoy OngSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
Wisna NoveraLaboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore.
Jianqing LinSchool of Biological Sciences, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0003-4336-9003
Rossarin SuwanaruskSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
Varakorn KosaisaveeDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Trang T T ChuPillar of Engineering Product Development, Singapore University of Technology & Design, Singapore, Singapore.
Ameya SinhaPillar of Engineering Product Development, Singapore University of Technology & Design, Singapore, Singapore.
Shanshan Wu HowlandSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.ORCID http://orcid.org/0000-0003-4794-1564
Yiping FanDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
Jakub GruszczykThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-4536-2964
Wai-Hong ThamThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0001-7950-8699
Yves ColinUniversité de Paris, UMR_S1134, BIGR, INSERM, Paris, France.
Sebastian Maurer-StrohA*STAR ID Labs, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.ORCID http://orcid.org/0000-0003-0813-9640
Georges SnounouCEA-Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases (IMVA-HB), IDMIT Department, IBFJ, DRF, Fontenay-aux-Roses, France.
Lisa F P NgSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.ORCID http://orcid.org/0000-0003-4071-5222
Jerry Kok Yen ChanDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
Ann-Marie ChackoLaboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore.ORCID http://orcid.org/0000-0001-5140-2622
Julien LescarSchool of Biological Sciences, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0002-9623-8130
Rajesh ChandramohanadasDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
François NostenShoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.ORCID http://orcid.org/0000-0002-7951-0745
Bruce Russell *Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0003-2333-4348
Laurent Rénia *Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore. Renia_Laurent@immunol.a-star.edu.sg.ORCID http://orcid.org/0000-0003-0349-1557
Agency for Science, Technology and Research · SGNational University of Singapore · SGSingapore University of Technology and Design · SGDuke-NUS Medical School · SGNanyang Technological University · SGInserm · FRMahidol University · THThe University of Melbourne · AUUniversité Paris-Sud · FRWalter and Eliza Hall Institute of Medical Research · AU
Funding
Wellcome Trust 208693/Z/17/Z
Abstract
More than one-third of the world's population is exposed to Plasmodium vivax malaria, mainly in Asia
Indexed as
Antigens, CDAntigens, ProtozoanErythrocytesFusion Regulatory Protein 1, Heavy ChainHost-Parasite InteractionsHumansMalaria, VivaxPlasmodium vivaxProtein BindingProtozoan ProteinsReceptors, Cell SurfaceReceptors, TransferrinReticulocytesAntigens, CDAntigens, ProtozoanCD71 antigenDuffy antigen binding protein, PlasmodiumFusion Regulatory Protein 1, Heavy ChainProtozoan ProteinsReceptors, Cell SurfaceReceptors, TransferrinSLC3A2 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.